First Trust Advisors LP cut its holdings in shares of Steris PLC (NYSE:STE) by 51.7% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 46,853 shares of the medical equipment provider’s stock after selling 50,182 shares during the period. First Trust Advisors LP’s holdings in Steris were worth $5,360,000 at the end of the most recent quarter.

A number of other large investors have also bought and sold shares of STE. Steward Partners Investment Advisory LLC boosted its position in Steris by 118.0% during the 3rd quarter. Steward Partners Investment Advisory LLC now owns 909 shares of the medical equipment provider’s stock worth $104,000 after buying an additional 492 shares during the period. First Hawaiian Bank acquired a new stake in Steris during the 3rd quarter worth approximately $106,000. Point72 Hong Kong Ltd acquired a new stake in Steris during the 2nd quarter worth approximately $116,000. Fort L.P. acquired a new stake in Steris during the 2nd quarter worth approximately $121,000. Finally, Centaurus Financial Inc. acquired a new stake in Steris during the 2nd quarter worth approximately $184,000. Institutional investors and hedge funds own 89.90% of the company’s stock.

Several equities research analysts recently commented on STE shares. Zacks Investment Research downgraded shares of Steris from a “buy” rating to a “hold” rating in a research report on Tuesday, July 24th. Stephens reiterated a “buy” rating and set a $125.00 target price on shares of Steris in a research report on Thursday, August 9th. KeyCorp lifted their target price on shares of Steris from $115.00 to $120.00 and gave the stock an “overweight” rating in a research report on Thursday, August 9th. Finally, JMP Securities lifted their target price on shares of Steris from $113.00 to $125.00 and gave the stock a “market outperform” rating in a research report on Thursday, August 9th. One research analyst has rated the stock with a hold rating and five have given a buy rating to the stock. Steris has an average rating of “Buy” and an average price target of $119.33.

In other news, CEO Walter M. Rosebrough, Jr. sold 10,000 shares of the business’s stock in a transaction that occurred on Wednesday, November 7th. The shares were sold at an average price of $120.50, for a total value of $1,205,000.00. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Michael J. Tokich sold 34,500 shares of the business’s stock in a transaction that occurred on Wednesday, November 7th. The stock was sold at an average price of $119.16, for a total transaction of $4,111,020.00. Following the completion of the transaction, the insider now owns 64,958 shares in the company, valued at approximately $7,740,395.28. The disclosure for this sale can be found here. 2.38% of the stock is currently owned by insiders.

Shares of NYSE STE opened at $115.75 on Tuesday. The company has a market capitalization of $10.00 billion, a PE ratio of 27.92 and a beta of 1.03. Steris PLC has a 52-week low of $82.88 and a 52-week high of $121.67. The company has a debt-to-equity ratio of 0.41, a quick ratio of 2.01 and a current ratio of 2.63.

Steris (NYSE:STE) last issued its quarterly earnings results on Tuesday, November 6th. The medical equipment provider reported $1.10 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.08 by $0.02. The firm had revenue of $679.00 million for the quarter, compared to the consensus estimate of $659.14 million. Steris had a net margin of 11.72% and a return on equity of 12.15%. The company’s revenue for the quarter was up 7.1% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.94 EPS. On average, equities research analysts expect that Steris PLC will post 4.79 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Friday, December 21st. Stockholders of record on Wednesday, November 28th will be given a $0.34 dividend. The ex-dividend date is Tuesday, November 27th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.17%. Steris’s dividend payout ratio (DPR) is currently 32.77%.

ILLEGAL ACTIVITY NOTICE: This piece of content was originally posted by Daily Political and is the property of of Daily Political. If you are accessing this piece of content on another domain, it was illegally copied and republished in violation of US and international trademark and copyright legislation. The correct version of this piece of content can be read at https://www.dailypolitical.com/2018/11/20/first-trust-advisors-lp-sells-50182-shares-of-steris-plc-ste.html.

Steris Profile

STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.

Further Reading: What is insider trading?

Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Steris PLC (NYSE:STE).

Institutional Ownership by Quarter for Steris (NYSE:STE)

Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.